<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pathogenesis of <z:hpo ids='HP_0003265'>neonatal hyperbilirubinemia</z:hpo> has not yet been completely defined in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate-dehydrogenase (G6PD)-deficient newborns </plain></SENT>
<SENT sid="1" pm="."><plain>The recent identification of a variant promoter in the gene encoding for the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="0" ids="16704">uridine</z:chebi>-diphosphoglucuronosyl-transferase (UGT-1 A) associated with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, allowed us to explore whether the presence of this variant promoter is a risk factor for the development of <z:hpo ids='HP_0003265'>neonatal hyperbilirubinemia</z:hpo> in <z:mpath ids='MPATH_458'>normal</z:mpath> newborns and in association with <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G6PD deficiency</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We found that the variant (TA)7/(TA)7 promoter shows no statistically significant difference in <z:mpath ids='MPATH_458'>normal</z:mpath> or G6PD-deficient newborns developing severe <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> and in control subjects from the same population </plain></SENT>
<SENT sid="3" pm="."><plain>This finding indicates that the variant promoter of UGT-1 A does not contribute to the development of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> in the newborn </plain></SENT>
</text></document>